International Collaborations
CoVICIS
EU-Africa Concerted Action On SARS-CoV-2 Virus Variant and Immunological Surveillance
EU-Africa Concerted Action On SARS-CoV-2 Virus Variant and Immunological Surveillance (CoVICIS) is a consortium funded by the EU Horizon Europe program. It is led by Centre Hospitalier Universitaire Vaudois (CHUV) involving 14 partners from 7 countries – Switzerland, Italy, France, Germany, the Netherlands, Ethiopia and South Africa. CoVICIS’ unique strength is its combined expertise with world leading scientists in the fields of epidemiology, genomics, virology, immunology, data science and public health, coupled with state-of-the-art cutting edge technologies in bioscience.
Its overarching objectives are to:
- Contributing to the early identification of emerging VOC
- Obtaining in-depth understanding of the risk and protective factors to SARS-CoV-2 infection as well as the evolution of the virus in different risk, gender and age groups.
EVF provides the overall management of this project.
